[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 298 Introduced in House (IH)]







109th CONGRESS
  1st Session
H. CON. RES. 298

Supporting the goals and ideals of National Lung Cancer Awareness Month 
and expressing the sense of the Congress that the Federal commitment to 
   lung cancer research and earlier detection must be significantly 
                               increased.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 15, 2005

   Mr. Shaw submitted the following concurrent resolution; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                         CONCURRENT RESOLUTION


 
Supporting the goals and ideals of National Lung Cancer Awareness Month 
and expressing the sense of the Congress that the Federal commitment to 
   lung cancer research and earlier detection must be significantly 
                               increased.

Whereas lung cancer is the leading cancer killer of both men and women;
Whereas lung cancer claims the lives of more people each year than breast, 
        prostate, colon, liver, melanoma, and kidney cancers combined;
Whereas the Surveillance, Epidemiology, and End Results (SEER) Program of the 
        National Cancer Institute estimates that 172,570 new lung cases will be 
        diagnosed in 2005 and 163,510 individuals will die of lung cancer in 
        2005;
Whereas in 2005, lung cancer will kill over three times as many men as prostate 
        cancer and nearly twice as many women as breast cancer;
Whereas the Lung Cancer Alliance points out that the 5-year survival rate for 
        lung cancer is still only 15 percent, virtually unchanged since the 
        National Cancer Act of 1971;
Whereas the 5-year survival rate is 99 percent for prostate cancer and 88 
        percent for breast cancer;
Whereas the overall Federal research commitment to lung cancer research in 2005 
        expressed in dollars per death is $1,829;
Whereas the overall Federal research commitment to research in 2005 expressed in 
        dollars per death is $23,474 for breast cancer and $14,369 for prostate 
        cancer;
Whereas both incidence and mortality rates for lung cancer are significantly 
        higher in black males;
Whereas veterans are at high risk for lung cancer due to the federally 
        subsidized distribution of cigarettes and exposure during combat to 
        known lung cancer carcinogens such as Agent Orange;
Whereas over 60 percent of new lung cancer cases are now being diagnosed in 
        people who never smoked or in former smokers who had already quit 
        smoking, many of them decades ago;
Whereas the majority of non-smokers being diagnosed with lung cancer are women, 
        many of them in their forties;
Whereas 70 percent of new lung cancer cases are not diagnosed until late stage 
        when the cancer has already metastasized;
Whereas the public is not aware of many of the statistics, the risk factors, or 
        the need for early diagnosis;
Whereas an early diagnosis can reduce deaths;
Whereas the Federal commitment to lung cancer research and earlier detection 
        must be significantly increased; and
Whereas the recognition of November as National Lung Cancer Awareness Month 
        would increase awareness about lung cancer and the need for lung cancer 
        research and early detection: Now, therefore, be it
    Resolved by the House of Representatives (the Senate concurring), 
That the Congress--
            (1) supports the goals and ideals of National Lung Cancer 
        Awareness Month;
            (2) should work to increase the Federal research commitment 
        to lung cancer research and early detection to the amount 
        necessary to bring the 5-year survival rate to 50 percent 
        within 10 years; and
            (3) should work with all Federal agencies involved in 
        cancer research to develop a coordinated road map for 
        accomplishing that goal.
                                 <all>